EMA: Cardiac risk for Sovaldi, Harvoni use with amiodarone
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has confirmed a risk of heart problems in hepatitis C patients taking Sovalidi (sofosbuvir), and other new hep C regimens, in combination with antiarrhythmic drug amiodarone.